In this study, the presence of AKT1 and SMO mutations along with mutated MYBL2, both in the NF2-mutant primary atypical meningioma tumor and the derived cell line, proved that the meningioma-derived primary cell line had retained the genetic signature of the original tumor. This evidence concerns the gene AKT1 and meningioma.